Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 2
1963 3
1965 1
1966 1
1967 2
1969 1
1970 2
1971 1
1972 1
1974 1
1975 1
1976 1
1977 2
1978 2
1979 6
1980 2
1981 2
1982 2
1983 10
1984 4
1985 6
1986 6
1987 10
1988 4
1989 5
1990 5
1991 6
1992 2
1993 1
1994 2
1995 3
1996 2
1997 4
1998 8
1999 4
2000 4
2001 4
2002 8
2003 18
2004 31
2005 23
2006 17
2007 22
2008 34
2009 25
2010 32
2011 49
2012 49
2013 65
2014 57
2015 57
2016 66
2017 54
2018 79
2019 63
2020 87
2021 103
2022 99
2023 103
2024 35

Text availability

Article attribute

Article type

Publication date

Search Results

1,170 results

Results by year

Filters applied: . Clear all
Page 1
Artificial intelligence in medical imaging of the liver.
Zhou LQ, Wang JY, Yu SY, Wu GG, Wei Q, Deng YB, Wu XL, Cui XW, Dietrich CF. Zhou LQ, et al. Among authors: yu sy. World J Gastroenterol. 2019 Feb 14;25(6):672-682. doi: 10.3748/wjg.v25.i6.672. World J Gastroenterol. 2019. PMID: 30783371 Free PMC article. Review.
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Pozo-Rosich P, Ailani J, Ashina M, Goadsby PJ, Lipton RB, Reuter U, Guo H, Schwefel B, Lu K, Boinpally R, Miceli R, De Abreu Ferreira R, McCusker E, Yu SY, Severt L, Finnegan M, Trugman JM. Pozo-Rosich P, et al. Among authors: yu sy. Lancet. 2023 Sep 2;402(10404):775-785. doi: 10.1016/S0140-6736(23)01049-8. Epub 2023 Jul 26. Lancet. 2023. PMID: 37516125 Clinical Trial.
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study.
Zhou Q, Xu CR, Cheng Y, Liu YP, Chen GY, Cui JW, Yang N, Song Y, Li XL, Lu S, Zhou JY, Ma ZY, Yu SY, Huang C, Shu YQ, Wang Z, Yang JJ, Tu HY, Zhong WZ, Wu YL. Zhou Q, et al. Among authors: yu sy. Cancer Cell. 2021 Sep 13;39(9):1279-1291.e3. doi: 10.1016/j.ccell.2021.07.005. Epub 2021 Aug 12. Cancer Cell. 2021. PMID: 34388377 Free article. Clinical Trial.
1,170 results